MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dyskinesias"

  • 2017 International Congress

    Tremor as the first symptom reported by Parkinson’s disease patients is a predictor of future motor subtype and levodopa-induced dyskinesia.

    A. Schumacher-Schuh, F. Drumond, J. Leal, M. Dotto, S. Machado, C. Rieder (Porto Alegre, Brazil)

    Objective: To better delineate risk profiles for the development of levodopa-induced dyskinesia is an important effort that can help understand this phenomenon and could impact…
  • 2017 International Congress

    Tremor-Dominant Clinical Phenotype is Associated with Low Risk of Levodopa-Induced Dyskinesia in Parkinson’s Disease

    B. Santos-Lobato, M. Capelari, N. Novaretti, Â. Vieira, V. Borges, H. Ferraz, I. Mata, C. Zabetian, V. Tumas (Ribeirão Preto, Brazil)

    Objective:  To evaluate possible associations between epidemiological and clinical data with risk of levodopa-induced dyskinesias (LID) onset in  Parkinson’s disease (PD) patients. Background: LID are…
  • 2017 International Congress

    Final validation of an electronic diary for motor fluctuations and dyskinesias evaluation in PD patients: Comparison with paperback diary.

    C. Terroba, A. Medina, F. Nanni, V. Bruno, D. Cerquetti, M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the reliability and compliance to an electronic motor diary in PD patients.  Background: Despite paper diaries are widely used, adherence, duplication, fraudulent…
  • 2017 International Congress

    Genetic variants influencing dyskinesia; potential consequences for treatment in Parkinson’s disease

    C. Kusters, K. Paul, I. Guella, J. Bronstein, J. Sinsheimer, M. Farrer, B. Ritz (Los Angeles, CA, USA)

    Objective: To examine the association between dyskinesia and haplotypes in the genes of three dopamine receptors (DRD1, DRD2 and DRD3) and of the Brain Derived…
  • 2017 International Congress

    Cause-Specific Hazard of Motor and Nonmotor Long Term Complications of Idiopathic Parkinson’s Disease in a Hospital-based Outpatient Clinic Incident Cohort of 1333 Patients

    S. Prange, C. Laurencin, t. danaila, m.-b. delphine, S. Thobois (bron, France)

    Objective: To compare the relative incidence rates, at identical disease duration, of motor and nonmotor clinical milestones in the long-term disease course of Parkinson’s disease…
  • 2017 International Congress

    Personal KinetiGraph (PKG) for Parkinson’s Disease: Experience at a Tertiary Care Center

    V. Sharma, A. Fowler, K. Lyons, R. Pahwa (Kansas City, KS, USA)

    Objective: To assess objective measurements by Personal KinetiGraph (PKG) in Parkinson’s disease (PD) patients and compare them to self-reported symptoms.   Background: Personal Kinetigraph (PKG)…
  • 2017 International Congress

    Knowledge of Levododopa-induced Dyskinesias among PD patients

    R. Doyle Maia, F. Cardoso, P. Caramelli (Vitória, Brazil)

    Objective: The aim of this study was to investigate the level of knowledge of LIDs in PD patients and their proxies in a tertiary hospital. …
  • 2017 International Congress

    Levodopa induced dyskinesia in a case of progressive supranuclear palsy.

    T. Yamamoto, H. Kawasaki, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, K. Takahashi, N. Tamura, N. Araki (Saitama, Japan)

    Objective: We describe the mechanism of dyskinesia in patients with progressive supranuclear palsy (PSP). Background: Levodopa generally shows a poor effect to parkinsonism in patients…
  • 2017 International Congress

    Protocol for upper-limb kinematic analysis in paediatric movement disorders and relative normality data

    L. Garavaglia, E. Pagliano, A. Lo Mauro, G. Baranello, A. Aliverti, S. Pittaccio (Lecco, Italy)

    Objective: The study proposes a specialised protocol to collect and analyse kinematic data from paediatric patients affected by Movement Disorders (MD). The aim is to…
  • 2017 International Congress

    Factors associated with occurrence of motor complications among Parkinson’s disease patients with levodopa treatment in Estonia

    L. Kadastik-Eerme, N. Taba, T. Asser, P. Taba (Tartu, Estonia)

    Objective: To identify the factors associated with the occurrence of motor complications among patients with Parkinson’s disease (PD) who receive levodopa treatment. Background:  Levodopa is the…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 40
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley